Literature DB >> 8721685

Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas.

H Ohnishi1, M Kawamura, R Hanada, Y Kaneko, Y Tsunoda, T Hongo, F Bessho, K Yokomori, Y Hayashi.   

Abstract

We have investigated the mutation of the TP53 gene in hepatoblastomas (HBLs) by using polymerase chain reaction-single strand conformation polymorphism and direct sequencing in 38 HBL tumor samples and in two HBL cell lines. We detected the TP53 gene mutation in an anaplastic hepatoblastoma cell line, but no aberration of the TP53 gene (exons 5-9) was found in tumor samples and in the other HBL cell line. The mutation of the cell line was a missense mutation from GAC (asparagine) to CAC (histidine) at codon 281, which was different from the G-to-T transversion of codon 249 that is frequently found in adult hepatocellular carcinomas (HCCs). In addition, we performed Southern blot analysis of the MDM2 gene, but we did not find MDM2 gene amplification in 19 cases tested. Our results suggest that, in contrast to the findings in HCCs in adults, TP53 gene aberrations are not involved in the development or progression of HBLs in children.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721685     DOI: 10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.

Authors:  Weiqi Zhang; Jennifer Meyfeldt; Huabo Wang; Sucheta Kulkarni; Jie Lu; Jordan A Mandel; Brady Marburger; Ying Liu; Joanna E Gorka; Sarangarajan Ranganathan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

Review 2.  The MDM2 gene amplification database.

Authors:  J Momand; D Jung; S Wilczynski; J Niland
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

3.  Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia.

Authors:  T Schlott; K Ahrens; I Ruschenburg; S Reimer; H Hartmann; M Droese
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

4.  Integrative Analysis of DNA Methylation and Gene Expression Profiling Data Reveals Candidate Methylation-Regulated Genes in Hepatoblastoma.

Authors:  Jian-Yao Wang; Jing Lao; Yu Luo; Jing-Jie Guo; Hao Cheng; Hong-Yan Zhang; Jun Yao; Xiao-Peng Ma; Bin Wang
Journal:  Int J Gen Med       Date:  2021-12-06

Review 5.  Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug Therapies.

Authors:  Rishi Raj Rikhi; Kimberlee K Spady; Ruth I Hoffman; Michael S Bateman; Max Bateman; Lisa Easom Howard
Journal:  Front Pediatr       Date:  2016-03-21       Impact factor: 3.418

6.  Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates.

Authors:  Shohei Honda; Masashi Minato; Hiromu Suzuki; Masato Fujiyoshi; Hisayuki Miyagi; Masayuki Haruta; Yasuhiko Kaneko; Kanako C Hatanaka; Eiso Hiyama; Takehiko Kamijo; Tadao Okada; Akinobu Taketomi
Journal:  Cancer Sci       Date:  2016-04-27       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.